Evidence Accumulates Against Angiotensin-Converting Enzyme Inhibitors and Beta-Adrenergic Blockers as Important Co-factors for Anaphylactic Reactions

Paul A. Greenberger*

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)1906-1907
Number of pages2
JournalJournal of Allergy and Clinical Immunology: In Practice
Volume8
Issue number6
DOIs
StatePublished - Jun 2020

Funding

This work was supported by the Ernest S. Bazley Foundation grants to Northwestern Memorial Hospital and Northwestern University. Conflicts of interest: The author declares that he has no relevant conflicts of interest. He does receive royalties from Wolters Kluwer for Up To Date reviews and a book royalty, research funding from the NIAID to Northwestern University, and medical legal fees for consulting.

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this